Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHST vs WEST: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

WEST Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–2 Matrix Metrics)

WEST Overall Winner 6-Pillar Tally: BHST 2 – 4 WEST Matrix Metrics: BHST 2 – 6 WEST

As of Nov 20, 2026, Westrock Coffee Company (WEST) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas WEST carries 44.7/100 (HOLD) at $7.22 (N/M Forward P/E, -1.2% operating margin).

  • Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. WEST 44.7/100 HOLD), WEST captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-1.2% vs. -18.0% operating margin) and revenue trajectory (-15.4% vs. +3.8% YoY).
  • Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile WEST trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 29.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHST vs WEST
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58
WEST NASDAQ Head-to-Head Winner
Westrock Coffee Company Common Stock
Beverages
$7.22
-1.37% 1D
Market Cap $732.5M
TTM Revenue $1.25B
Forward P/E N/M
Beta / 30D Vol 0.56β · 69% Vol
Unified Composite Score
44.7 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 58.0 Mom 55.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 29
RSI-14: 29.2 · SMA20: $8.99 · SMA50: $8.57

6-Pillar Scorecard Institutional Category Breakdown (BHST 2 – 4 WEST)

Columns: Metric · BHST · WEST
1. Valuation Multiples BHST
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.7x 1.0x
2. Growth & Scale WEST
Revenue Growth (YoY) +3.8% -15.4%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $35M $1.25B
Market Cap $29.9M $732.5M
3. Profitability & Quality WEST
Gross Margin 59.0% 10.9%
Operating Margin -18.0% -1.2%
Net Profit Margin -31.2% -4.4%
Return on Equity (ROE) -142.5% -20.9%
4. Balance Sheet & Cash Flow WEST
Cash Generation (TTM) -$9.4M $30M
Cash Flow Margin -26.6% 2.4%
Net Cash / Leverage $5.1M Net Cash $523M Net Debt (2.37x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning WEST
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 48.8% (5th %ile)
Put/Call OI Skew N/A 3.87x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 77.0% of Rev ($27M) 12.1% of Rev ($152M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHST (2) vs WEST (6)
Institutional Metric BHST WEST Criterion Row Edge
Market Capitalization
Scale
$29.9M $732.5M Larger Scale WEST
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+3.8% -15.4% Higher Growth BHST
Operating Margin (TTM)
Profitability
-18.0% -1.2% Higher Margin WEST
Net Profit Margin
Profitability
-31.2% -4.4% Higher Margin WEST
Return on Equity (ROE)
Capital Efficiency
-142.5% -20.9% Higher ROE WEST
52-Week Range Position
Momentum
6% ($1–$7) 49% ($4–$11) Stronger Trend WEST
Beta / 30D Volatility
Risk Regime
0.25β · 86% Vol 0.56β · 69% Vol Lower Realized Risk WEST
Unified Institutional Score
Composite Signal
58.2 / 100 (HOLD) 44.7 / 100 (HOLD) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$35M $1.25B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
59.0% 10.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.7x EV/Rev N/M PEG · 1.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$9.4M ($5.1M Net Cash) $30M ($523M Net Debt (2.37x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHST +2.87 pp
BHST: -22.62% · WEST: -25.49%
3M Horizon WEST +22.14 pp
BHST: -36.59% · WEST: -14.45%
6M Horizon WEST +52.79 pp
BHST: -66.32% · WEST: -13.53%
1Y Horizon WEST +152.54 pp
BHST: -79.4% · WEST: +73.14%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period BHST Revenue WEST Revenue BHST Op. Margin WEST Op. Margin Margin Leader
FY2020 N/A $550M N/A -21.9% WEST
FY2021 N/A $700M N/A 1.1% WEST
FY2022 N/A $870M N/A 1.0% WEST
FY2023 $10M $860M -78.6% -2.4% WEST
FY2024 $30M $850M -27.7% -5.8% WEST
FY2025 $30M $1.19B -16.2% -3.8% WEST

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
WEST CONSOLIDATION
112d in phase · OBV DISTRIBUTION
Current IV 48.8%
IV Percentile 5th %ile
Put/Call OI Skew 3.87x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact WEST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published
WEST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $732.5M market capitalization and -1.2% operating margin.
OpEx & R&D Reinvestment 12.1% of Rev ($152M)
90D Engineering Disclosures 0 Published

Investor FAQ BHST vs WEST Key Questions & Quantitative Answers

As of Nov 20, 2026, Westrock Coffee Company (WEST) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas WEST carries 44.7/100 (HOLD) at $7.22 (N/M Forward P/E, -1.2% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. WEST 44.7/100 HOLD), WEST captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-1.2% vs. -18.0% operating margin) and revenue trajectory (-15.4% vs. +3.8% YoY). Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile WEST trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 29.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

WEST leads the Growth & Scale pillar: BHST posts +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin), compared with WEST at -15.4% YoY revenue growth and +0.0% YoY earnings growth on $1.25B TTM revenue (10.9% gross margin, -1.2% operating margin). Across the 6-period historical trajectory (FY2020 to FY2025), BHST cumulative revenue shifted +200.0% while WEST shifted +116.4%. In operating R&D and SG&A reinvestment, BHST deploys 77.0% of Rev ($27M) (0 90-day corporate R&D disclosures) versus 12.1% of Rev ($152M) (0 disclosures) for WEST.

BHST screens cheaper on headline valuation multiples. BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin), whereas WEST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.0x EV/Revenue (2.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHST (-142.5% ROE) versus WEST (-20.9% ROE) capital efficiency.

In options market volatility and institutional positioning, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk). By comparison, WEST carries 48.8% implied volatility (5th %ile, Compressed (<25th %ile)), a 3.87x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.56β · 69% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.